Abstract:Background Microbleeds (CMBs) serve as neuroimaging biomarkers to assess risk of intracerebral hemorrhage and diagnose cerebral small vessel disease (CSVD). Therefore, detecting CMBs can evaluate the risk of intracerebral hemorrhage and use its presence to support CSVD classification, both are conducive to optimizing CSVD management. This study aimed to develop and test a deep learning (DL) model based on susceptibility-weighted MR sequence (SWS) to detect CMBs and classify CSVD to assist neurologists in optimizing CSVD management. Methods Patients with arteriolosclerosis (aSVD), cerebral amyloid angiopathy (CAA), and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) treated at three centers were enrolled between January 2017 and May 2022 in this retrospective study. The SWSs of patients from two centers were used as the development set, and the SWSs of patients from the remaining center were used as the external test set. The DL model contains a Mask R-CNN for detecting CMBs and a multi-instance learning (MIL) network for classifying CSVD. The metrics for model performance included intersection over union (IoU), Dice score, recall, confusion matrices, receiver operating characteristic curve (ROC) analysis, accuracy, precision, and F1-score. Results A total of 364 SWS were recruited, including 336 in the development set and 28 in the external test set. IoU for the model was 0.523 ± 0.319, Dice score 0.627 ± 0.296, and recall 0.706 ± 0.365 for CMBs detection in the external test set. For CSVD classification, the model achieved a weighted-average AUC of 0.908 (95% CI: 0.895-0.921), accuracy of 0.819 (95% CI: 0.768-0.870), weighted-average precision of 0.864 (95% CI: 0.831-0.897), and weighted-average F1-score of 0.829 (95% CI: 0.782-0.876) in the external set, outperforming the performance of the neurologist group. Conclusion The DL model based on SWS can detect CMBs and classify CSVD, thereby assisting neurologists in optimizing CSVD management. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial This study was conducted following the Declaration of Helsinki. Requirements for informed consent were waived because of the study's retrospective nature. ### Funding Statement This work was supported by the National Natural Science Foundation of China (Grant No. 81971110 and 82171307), the Key Areas R&D Program of Science and Technology Program of Guangzhou (Grant No. 202206060001), the Science and Technology Program of Guangzhou (Grant No. 202007030010), and the High-level Hospital Construction Research Project of Maoming People's Hospital, the Science and Technology Special Fund Program of Maoming (Grant No. 2020KJZX006). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Medical Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes The Medical Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University approved this retrospective multicenter study. <https://github.com/Huatsing-Lau/CSVD-CMBs-Detection-and-Classification.git> * CMBs : microbleeds CSVD : cerebral small vessel disease DL : deep learning SWS : susceptibility-weighted MR sequence aSVD : arteriolosclerosis CAA : cerebral amyloid angiopathy CADASIL : cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy MIL : multi-instance learning IoU : intersection over union ROC : receiver operating characteristic curve AUC : area under receiver operating characteristic curve SWAN : T2-star-weighted angiography SWI : susceptibility-weighted imaging STRIVE : STandards for ReportIng Vascular changes on nEurouimaging SYSUTH : Third Affiliated Hospital, Sun Yat-sen University (SYSUTH) MMPH : Maoming People’s Hospital STUMFH : First Affiliated Hospital of SHANTOU University Medical College SD : standard deviation Grad-CAM : Gradient-weighted Class Activation Mapping CI : confidence interval 3D-CNN : three-dimensional convolutional neural network 2D-CNN : two-dimensional convolutional neural network

Quantitative Analysis of Multimodal MRI Markers and Clinical Risk Factors for Cerebral Small Vessel Disease Based on Deep Learning

Computer-aided extraction of select MRI markers of cerebral small vessel disease: A systematic review

Application of artificial intelligence‐based magnetic resonance imaging in diagnosis of cerebral small vessel disease

Advancing cerebral small vessel disease diagnosis: Integrating quantitative susceptibility mapping with MRI-based radiomics

Progress of deep learning in cerebral small vessel disease imaging markers

Primary Categorizing and Masking Cerebral Small Vessel Disease Based on "deep Learning System".

Cerebral Microbleed Automatic Detection System Based on the “Deep Learning”

Segmentation of Cerebral Small Vessel Diseases-White Matter Hyperintensities Based on a Deep Learning System

Deep learning based on susceptibility-weighted MR sequence for detecting cerebral microbleeds and classifying cerebral small vessel disease

Unraveling the Predictors of Enlarged Perivascular Spaces: A Comprehensive Logistic Regression Approach in Cerebral Small Vessel Disease

Automated quantification of cerebral microbleeds in susceptibility-weighted MRI: association with vascular risk factors, white matter hyperintensity burden, and cognitive function

Decreased Visible Deep Medullary Veins is a Novel Imaging Marker for Cerebral Small Vessel Disease.

Automatic segmentation of hemispheric CSF on MRI using deep learning: Quantifying cerebral edema following large hemispheric infarction

Machine Learning for Selecting Important Clinical Markers of Imaging Subgroups of Cerebral Small Vessel Disease Based on a Common Data Model

Quantitative Modeling of Lenticulostriate Arteries on 7-T TOF-MRA for Cerebral Small Vessel Disease

Deep Learning using Susceptibility-Weighted MR Sequence to Detect Microbleeds and Classify Cerebral Small Vessel Disease

A Neural Network Approach to Segment Brain Blood Vessels in Digital Subtraction Angiography

Automatic segmentation and diameter measurement of deep medullary veins

Establishment and validation of a risk stratification model for stroke risk within three years in patients with cerebral small vessel disease using a combined MRI and machine learning algorithm

Accurate and robust segmentation of cerebral vasculature on four-dimensional arterial spin labeling magnetic resonance angiography using machine-learning approach

Automated in-depth cerebral arterial labelling using cerebrovascular vasculature reframing and deep neural networks